Editorial Type:
Article Category: Research Article
 | 
Online Publication Date: 01 Jan 2014

What is the difference? Within class comparisons of psychotropic agents with new products

PharmD, BCPP
Page Range: 2 – 7
DOI: 10.9740/mhc.n186968
Save
Download PDF

When ‘new’ psychotropic medications are released on the market, it can be difficult to discern the differences between the newer agents and their similar predecessors. Since head to head clinical trials are rarely available, it is important to learn what can be gleaned from the package inserts and the Food and Drug Administration (FDA) website. These sources are a wealth of information and were used as the primary resources for the comparative tables that follow.

Table 1. Serotonin Norepinephrine Reuptake Inhibitors-FDA Approvals
Table 1.
Table 2. Serotonin Norepinephrine Reuptake Inhibitors-Pharmacokinetic Comparison
Table 2.
Table 3. Selective Serotonin Reuptake Inhibitors
Table 3.
Table 4. Bupropion Products11
Table 4.
Table 5. Guanfacine IR vs Intuniv (note: Pharmacokinetics based on adult data)
Table 5.
Table 6. Amphetamine Based Products
Table 6.
Table 7. Valproate Products25–29
Table 7.
Table 8. Atypical Antipsychotics11
Table 8.
Copyright: © 2014 College of Psychiatric and Neurologic Pharmacists
  • Download PDF